{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:11:56Z","timestamp":1770095516441,"version":"3.49.0"},"reference-count":117,"publisher":"Elsevier","isbn-type":[{"value":"9780443431708","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.vh.2025.08.007","type":"book-chapter","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:34:01Z","timestamp":1765802041000},"page":"217-253","source":"Crossref","is-referenced-by-count":0,"title":["Low-renin hypertension"],"prefix":"10.1016","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Goi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2025.08.007_bib0001","first-page":"dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","author":"Adler","year":"2025","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/M17-2237","article-title":"Subclinical primary aldosteronism","volume":"167","author":"Adlin","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0003","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ajh\/hpt091","article-title":"Bimodal aldosterone distribution in low-renin hypertension","volume":"26","author":"Adlin","year":"2013","journal-title":"American Journal of Hypertension"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjhyper.2003.08.015","article-title":"Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients","volume":"17","author":"Alderman","year":"2004","journal-title":"American Journal of Hypertension"},{"issue":"4812","key":"10.1016\/bs.vh.2025.08.007_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/bs.vh.2025.08.007_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846865","article-title":"11-Deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: Case report and systematic review of the literature","volume":"13","author":"Asla","year":"2022","journal-title":"Frontiers in endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/hy1201.101214","article-title":"History about the discovery of the renin-angiotensin system","volume":"38","author":"Basso","year":"2001","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0008","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: Genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2025.08.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111168","article-title":"Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess","volume":"524","author":"Beck","year":"2021","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0010","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfq747","article-title":"A case of pheochromocytoma presenting as secondary hyperaldosteronism, hyperparathyroidism, diabetes and proteinuric renal disease","volume":"26","author":"Bernini","year":"2011","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ki.1992.39","article-title":"Pressure dependent modulation of renin release in isolated perfused glomeruli","volume":"41","author":"Bock","year":"1992","journal-title":"Kidney international"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00431-011-1581-8","article-title":"Liddle syndrome in a Serbian family and literature review of underlying mutations","volume":"171","author":"Bogdanovi\u0107","year":"2012","journal-title":"European Journal of Pediatrics"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0013","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The Spectrum of subclinical primary aldosteronism and incident hypertension: A cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.jhh.1001511","article-title":"Better blood pressure control: How to combine drugs","volume":"17","author":"Brown","year":"2003","journal-title":"Journal of Human Hypertension"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","article-title":"Essential hypertension: Renin and aldosterone, heart attack and stroke","volume":"286","author":"Brunner","year":"1972","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101399","article-title":"The spectrum of low-renin hypertension","volume":"34","author":"Buffolo","year":"2020","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.007_bib0017","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0002-9149(73)80047-5","article-title":"Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone","volume":"32","author":"B\u00fchler","year":"1973","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.007_bib0018","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"6462","key":"10.1016\/bs.vh.2025.08.007_bib0019","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/367463a0","article-title":"Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits","volume":"367","author":"Canessa","year":"1994","journal-title":"Nature"},{"issue":"Pt 6","key":"10.1016\/bs.vh.2025.08.007_bib0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1258\/acb.2012.011186","article-title":"A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction","volume":"49","author":"Carter","year":"2012","journal-title":"Annals of Clinical Biochemistry"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0021","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00011.2009","article-title":"Physiology of kidney renin","volume":"90","author":"Castrop","year":"2010","journal-title":"Physiological Reviews"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0022","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1002\/j.2040-4603.2024.tb00807.x","article-title":"Familial hyperkalemic hypertension","volume":"14","author":"Cornelius","year":"2024","journal-title":"Comprehensive Physiology"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0023","doi-asserted-by":"crossref","first-page":"luad039","DOI":"10.1210\/jcemcr\/luad039","article-title":"Abiraterone-induced endocrinopathies","volume":"1","author":"Decamps","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0024","doi-asserted-by":"crossref","first-page":"R1517","DOI":"10.1152\/ajpregu.2000.279.5.R1517","article-title":"Neural control of the kidney: Functionally specific renal sympathetic nerve fibers","volume":"279","author":"DiBona","year":"2000","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.007_bib0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","article-title":"Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: A randomized controlled trial","volume":"22","author":"Egan","year":"2009","journal-title":"American Journal of Hypertension"},{"issue":"10108","key":"10.1016\/bs.vh.2025.08.007_bib0026","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0027","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0028","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0029","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of Baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trsl.2014.06.007","article-title":"Epigenetics and arterial hypertension: The challenge of emerging evidence","volume":"165","author":"Friso","year":"2015","journal-title":"Translational research : the journal of laboratory and clinical medicine"},{"issue":"Pt A","key":"10.1016\/bs.vh.2025.08.007_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.03.010","article-title":"Apparent mineralocorticoid excess","volume":"165","author":"Funder","year":"2017","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0032","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0033","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/CIRCULATIONAHA.104.492348","article-title":"Renovascular hypertension and ischemic nephropathy","volume":"112","author":"Garovic","year":"2005","journal-title":"Circulation"},{"issue":"5476","key":"10.1016\/bs.vh.2025.08.007_bib0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0039-128X(01)00119-2","article-title":"The 11beta hydroxysteroid dehydrogenase 2 exists as an inactive dimer","volume":"66","author":"Gomez-Sanchez","year":"2001","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2015.12.061","article-title":"Epithelial sodium channel (enac) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases","volume":"579","author":"Hanukoglu","year":"2016","journal-title":"Gene"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0037","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1210\/clinem\/dgad516","article-title":"Approach to the patient: Reninoma","volume":"109","author":"Hayes","year":"2024","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0038","article-title":"Geller syndrome: A rare cause of persistent hypokalemia during pregnancy","volume":"14","author":"Hindosh","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0039","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.007_bib0040","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.ekir.2021.07.025","article-title":"The variety of genetic defects explains the phenotypic heterogeneity of familial hyperkalemic hypertension","volume":"6","author":"Hureaux","year":"2021","journal-title":"Kidney international reports"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0041","doi-asserted-by":"crossref","first-page":"F545","DOI":"10.1152\/ajprenal.00187.2006","article-title":"WNK4 enhances TRPV5-mediated calcium transport: Potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4","volume":"292","author":"Jiang","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.007_bib0042","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ng1271","article-title":"WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion","volume":"35","author":"Kahle","year":"2003","journal-title":"Nature Genetics"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0043","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/1440-1681.12177","article-title":"Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension","volume":"40","author":"Kawarazaki","year":"2013","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0044","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia","volume":"23","author":"Krone","year":"2009","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"issue":"19","key":"10.1016\/bs.vh.2025.08.007_bib0045","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity","volume":"80","author":"Krozowski","year":"1983","journal-title":"PNAS"},{"issue":"18","key":"10.1016\/bs.vh.2025.08.007_bib0046","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2501440","article-title":"Lorundrostat efficacy and safety in patients with uncontrolled hypertension","volume":"392","author":"Laffin","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0047","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: The target-htn randomized clinical trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0048","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9378(76)90480-4","article-title":"Oral contraceptives\u2013induced hypertension\u2013nine years later","volume":"126","author":"Laragh","year":"1976","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0049","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(72)90054-X","article-title":"Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease","volume":"52","author":"Laragh","year":"1972","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(72)90160-X","article-title":"The control of aldosterone secretion in normal and hypertensive man: Abnormal renin-aldosterone patterns in low renin hypertension","volume":"53","author":"Laragh","year":"1972","journal-title":"American Journal of Medicine"},{"issue":"10 Pt 2","key":"10.1016\/bs.vh.2025.08.007_bib0051","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/clinchem\/37.10.1820","article-title":"Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: Implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke)","volume":"37","author":"Laragh","year":"1991","journal-title":"Clinical Chemistry"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0052","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ajh.2011.171","article-title":"The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure","volume":"24","author":"Laragh","year":"2011","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0053","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.HYP.0000083340.57063.35","article-title":"Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene","volume":"42","author":"Lavery","year":"2003","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"10.1016\/bs.vh.2025.08.007_bib0054","first-page":"199","article-title":"A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion","volume":"76","author":"Liddle","year":"1963","journal-title":"Trans Assoc Am Phys"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12967-022-03698-9","article-title":"Apparent mineralocorticoid excess: Comprehensive overview of molecular genetics","volume":"20","author":"Lu","year":"2022","journal-title":"Journal of translational medicine"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0056","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006986","article-title":"Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: A double-blind randomized controlled trial","volume":"6","author":"MacDonald","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0057","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"38","key":"10.1016\/bs.vh.2025.08.007_bib0058","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"European Heart Journal"},{"issue":"14","key":"10.1016\/bs.vh.2025.08.007_bib0059","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.007_bib0061","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low-renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clinical Endocrinology"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0062","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/jhh.2017.34","article-title":"Familial hyperaldosteronism type III","volume":"31","author":"Monticone","year":"2017","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/bs.vh.2025.08.007_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105988","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: the glycyrrhetinic acid-like factor (GALF) hypothesis","volume":"214","author":"Morris","year":"2021","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0064","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","article-title":"Approach to the patient on antihypertensive therapy: Screen for primary aldosteronism","volume":"107","author":"Mulatero","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.007_bib0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.007_bib0066","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial hyperaldosteronism: An European reference network on rare endocrine conditions clinical practice guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"European Journal of Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0067","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: The PATOGEN study (Primary aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0068","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.007_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102576","article-title":"Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: A randomised, parallel group, multicentre, phase 2 trial","volume":"71","author":"Mulatero","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"22","key":"10.1016\/bs.vh.2025.08.007_bib0071","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1073\/pnas.96.22.12790","article-title":"Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess","volume":"96","author":"New","year":"1999","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0072","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/eci.12426","article-title":"Chrousos syndrome: From molecular pathogenesis to therapeutic management","volume":"45","author":"Nicolaides","year":"2015","journal-title":"European Journal of Clinical Investigation"},{"issue":"19","key":"10.1016\/bs.vh.2025.08.007_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910839","article-title":"Primary generalized glucocorticoid resistance and hypersensitivity syndromes: A 2021 update","volume":"22","author":"Nicolaides","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2025.08.007_bib0074","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4419-8002-1_10","article-title":"Apparent mineralocorticoid excess - update","volume":"707","author":"Nimkarn","year":"2011","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/bs.vh.2025.08.007_bib0075","series-title":"GeneReviews\u00ae","article-title":"21-Hydroxylase-deficient congenital adrenal hyperplasia","author":"Nimkarn","year":"2002"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0076","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.CIR.52.1.146","article-title":"Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a \"no-salt\" culture","volume":"52","author":"Oliver","year":"1975","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0077","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00467-014-2956-7","article-title":"Gordon syndrome: A continuing story","volume":"30","author":"O'Shaughnessy","year":"2015","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0078","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jch.12450","article-title":"Liddle syndrome phenotype in an octogenarian","volume":"17","author":"Pepersack","year":"2015","journal-title":"Journal of Clinical Hypertension (Greenwich, Conn.)"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.007_bib0079","first-page":"3197","article-title":"Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia","volume":"86","author":"Portrat","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.117.10111","article-title":"Old and new concepts in the molecular pathogenesis of primary aldosteronism","volume":"70","author":"Prada","year":"2017","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"13","key":"10.1016\/bs.vh.2025.08.007_bib0081","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.280.13.1168","article-title":"Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans affairs cooperative study group on antihypertensive agents","volume":"280","author":"Preston","year":"1998","journal-title":"JAMA"},{"issue":"1-2","key":"10.1016\/bs.vh.2025.08.007_bib0082","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.10.019","article-title":"Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population","volume":"217","author":"Quinkler","year":"2004","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0083","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1210\/jc.2003-030138","article-title":"Hypertension and the cortisol-cortisone shuttle","volume":"88","author":"Quinkler","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0084","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.007_bib0085","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41588-023-01498-5","article-title":"Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism","volume":"55","author":"Rege","year":"2023","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0086","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/bs.vh.2025.08.007_bib0087","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2016.04.109","article-title":"Effect of sodium intake on renin level: analysis of general population and meta-analysis of randomized controlled trials","volume":"215","author":"Rhee","year":"2016","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0088","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ajmg.1320420617","article-title":"High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco","volume":"42","author":"R\u00f6sler","year":"1992","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/bs.vh.2025.08.007_bib0089","article-title":"Lorundrostat in participants with uncontrolled hypertension and treatment-resistant hypertension: The launch-HTN randomized clinical trial","author":"Saxena","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.007_bib0090","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/j.1460-2075.1996.tb00594.x","article-title":"Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome","volume":"15","author":"Schild","year":"1996","journal-title":"Embo Journal"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0091","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"10.1016\/bs.vh.2025.08.007_bib0092","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0093","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0094","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0001-2998(75)80033-X","article-title":"Radioimmunoassay of plasma renin activity","volume":"5","author":"Sealey","year":"1975","journal-title":"Seminars in Nuclear Medicine"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2265.1985.tb00160.x","article-title":"Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: Corticosteroid metabolite profiles of four patients and their families","volume":"22","author":"Shackleton","year":"1985","journal-title":"Clinical Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.007_bib0096","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/HYPERTENSIONAHA.124.23385","article-title":"Update on low-renin hypertension: Current understanding and future direction","volume":"81","author":"Shah","year":"2024","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0097","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41371-023-00891-1","article-title":"Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: A systematic review and meta-analysis","volume":"38","author":"Shah","year":"2024","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0098","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical Renin-Angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Comprehensive Physiology"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.007_bib0099","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jc.2018-01197","article-title":"Clinical, biochemical, and genetic characteristics of \"nonclassic\" apparent mineralocorticoid excess syndrome","volume":"104","author":"Tapia-Castillo","year":"2019","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96628-6","article-title":"Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess","volume":"11","author":"Tapia-Castillo","year":"2021","journal-title":"Scientific Reports"},{"issue":"15","key":"10.1016\/bs.vh.2025.08.007_bib0101","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.3390\/ijms25158453","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescence for screening of patients with primary aldosteronism","volume":"25","author":"Tetti","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.007_bib0102","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/HYPERTENSIONAHA.124.23500","article-title":"Prevalence of hyperkalemia and familial hyperkalemic hypertension in 5100 patients referred to a tertiary hypertension unit","volume":"81","author":"Tetti","year":"2024","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0103","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: Review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.007_bib0104","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMc2508629","article-title":"Phase 2a study of Baxdrostat in primary aldosteronism","volume":"393","author":"Turcu","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.007_bib0105","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ajh.2010.98","article-title":"Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension","volume":"23","author":"Turner","year":"2010","journal-title":"American Journal of Hypertension"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.007_bib0106","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: State-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"American Journal of Hypertension"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0107","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: Implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0109","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0035-1548868","article-title":"Renin and aldosterone measurements in the management of arterial hypertension","volume":"47","author":"Viola","year":"2015","journal-title":"Hormone and Metabolic Research"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.007_bib0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3803\/EnM.2017.32.3.332","article-title":"CTNNB1 mutation in aldosterone producing adenoma","volume":"32","author":"Wang","year":"2017","journal-title":"Endocrinology and metabolism (Seoul, Korea)"},{"key":"10.1016\/bs.vh.2025.08.007_bib0111","series-title":"Guideline: Sodium Intake for Adults and Children","year":"2012"},{"issue":"10008","key":"10.1016\/bs.vh.2025.08.007_bib0112","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.007_bib0113","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"17","key":"10.1016\/bs.vh.2025.08.007_bib0114","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","article-title":"A genetic defect resulting in mild low-renin hypertension","volume":"95","author":"Wilson","year":"1998","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.007_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nyas.13162","article-title":"A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred","volume":"1376","author":"Yau","year":"2016","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"52","key":"10.1016\/bs.vh.2025.08.007_bib0116","doi-asserted-by":"crossref","first-page":"E11248","DOI":"10.1073\/pnas.1716621115","article-title":"Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"114","author":"Yau","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/bs.vh.2025.08.007_bib0117","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coemr.2019.07.001","article-title":"The prevalence of primary aldosteronism and evolving approaches for treatment","volume":"8","author":"Yozamp","year":"2019","journal-title":"Current opinion in endocrine and metabolic research"}],"container-title":["Vitamins and Hormones","Primary Aldosteronism: Physiopathology and Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:06:53Z","timestamp":1770052013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431708"],"references-count":117,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.08.007","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}